表紙
市場調查報告書

肺癌症治療藥的全球市場

Lung Cancer Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 912546
出版日期 內容資訊 英文 143 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肺癌症治療藥的全球市場 Lung Cancer Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 143 Pages
簡介

本報告提供全球肺癌症治療藥市場調查,提供市場概要,各類型(非小細胞肺癌/NSCLE,小細胞肺癌症/SCLC),各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲各國
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他的亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美地區
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競爭情形

  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER, INC

第5章 調查資料

目錄
Product Code: MCP-1873

Lung Cancer Therapeutics market worldwide is projected to grow by US$24 Billion, driven by a compounded growth of 12.9%. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed and sized in this study, displays the potential to grow at over 14%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$28.1 Billion by the year 2025, Non-Small-Cell Lung Cancer (NSCLC) will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$948.9 Million to the region's size and clout in the next 5 to 6 years. Over US$771 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Non-Small-Cell Lung Cancer (NSCLC) will reach a market size of US$1.4 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.7% over the next couple of years and add approximately US$5.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Lung Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Lung Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Lung Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Lung Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Non-Small-Cell Lung Cancer (NSCLC) (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Small-Cell Lung Cancer (SCLC) (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Small-Cell Lung Cancer (SCLC) (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Small-Cell Lung Cancer (SCLC) (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Lung Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 11: Lung Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 12: United States Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 14: Canadian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 15: Lung Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 17: Lung Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 18: Japanese Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 20: Lung Cancer Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 21: Chinese Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Lung Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Lung Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 23: Lung Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 24: European Lung Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 26: Lung Cancer Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 27: European Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Lung Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 29: French Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 30: French Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Lung Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 32: German Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 33: German Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 35: Lung Cancer Therapeutics Historic Market Analysis in Italy in US$ Million
    • by Type: 2009-2017
    • TABLE 36: Italian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 38: Lung Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 39: United Kingdom Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 40: Spanish Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 41: Spanish Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 42: Lung Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 43: Russian Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 44: Lung Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 45: Russian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 47: Lung Cancer Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 48: Rest of Europe Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 50: Lung Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 51: Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 52: Lung Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 53: Asia-Pacific Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 54: Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 55: Lung Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 56: Australian Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 57: Australian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 58: Indian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 59: Indian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 60: Lung Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 61: Lung Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 62: South Korean Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 63: Lung Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 65: Lung Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 66: Rest of Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 67: Latin American Lung Cancer Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 68: Lung Cancer Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 69: Latin American Lung Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 70: Latin American Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 71: Lung Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 72: Latin American Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 73: Argentinean Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 74: Lung Cancer Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 75: Argentinean Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 76: Lung Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 77: Brazilian Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 78: Brazilian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 79: Lung Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 80: Mexican Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 81: Mexican Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 83: Lung Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 84: Rest of Latin America Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 85: The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 86: Lung Cancer Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 87: The Middle East Lung Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 88: The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 89: The Middle East Lung Cancer Therapeutics Historic Market by Type in US$ Million: 2009-2017
    • TABLE 90: Lung Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 91: Iranian Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 92: Lung Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 93: Iranian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 94: Israeli Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 95: Lung Cancer Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 96: Israeli Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 98: Lung Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 99: Saudi Arabian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 100: Lung Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 101: United Arab Emirates Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 102: Lung Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 103: Lung Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 104: Rest of Middle East Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 105: Rest of Middle East Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 106: African Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 107: Lung Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 108: African Lung Cancer Therapeutics Market Share Breakdown by Type:
  • 2009 VS 2019 VS 2025

IV. COMPETITION

  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER, INC

V. CURATED RESEARCH

Back to Top